Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
REVENUES:    
Product revenue, net $ 7,768
COSTS AND EXPENSES:    
Cost of sales 4,741
Research and development 86,655 81,876
General and administrative 34,752 30,215
 Total Operating Expenses 126,148 112,091
Operating loss (118,380) (112,091)
Other income, net 1,722 1,873
Net loss (116,658) (110,218)
Preferred stock deemed dividend 6,659
Net loss available to common stockholders $ (116,658) $ (116,877)
Net loss per common share, basic $ (6.85) $ (20.01)
Net loss per common share, diluted $ (6.85) $ (20.01)
Weighted average common shares outstanding, basic 17,039,309 5,841,447
Weighted average common shares outstanding, diluted 17,039,309 5,841,447